You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CLINICAL TRIALS PROFILE FOR LIPOFEN


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for LIPOFEN

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01752842 ↗ Lipid Biomarkers for Diabetic Heart Disease Completed Leducq Foundation N/A 2013-03-01 This study will test whether lowering the delivery of excess fats to the heart in persons with type-2 diabetes mellitus improves heart muscle function. The investigators will also test whether specific lipid molecular species in plasma can serve as biomarkers for diabetic heart disease.
NCT01752842 ↗ Lipid Biomarkers for Diabetic Heart Disease Completed National Heart, Lung, and Blood Institute (NHLBI) N/A 2013-03-01 This study will test whether lowering the delivery of excess fats to the heart in persons with type-2 diabetes mellitus improves heart muscle function. The investigators will also test whether specific lipid molecular species in plasma can serve as biomarkers for diabetic heart disease.
NCT01752842 ↗ Lipid Biomarkers for Diabetic Heart Disease Completed National Institutes of Health (NIH) N/A 2013-03-01 This study will test whether lowering the delivery of excess fats to the heart in persons with type-2 diabetes mellitus improves heart muscle function. The investigators will also test whether specific lipid molecular species in plasma can serve as biomarkers for diabetic heart disease.
NCT01752842 ↗ Lipid Biomarkers for Diabetic Heart Disease Completed Washington University School of Medicine N/A 2013-03-01 This study will test whether lowering the delivery of excess fats to the heart in persons with type-2 diabetes mellitus improves heart muscle function. The investigators will also test whether specific lipid molecular species in plasma can serve as biomarkers for diabetic heart disease.
NCT02158273 ↗ Medication Development in Alcoholism: Investigating PPAR Agonists Completed National Institute on Alcohol Abuse and Alcoholism (NIAAA) Phase 2 2014-05-01 The primary hypotheses under test are that alcohol dependent subjects treated with fenofibrate will report decreased craving for alcohol following cue-exposure in the laboratory and report less drinking post treatment relative to placebo.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for LIPOFEN

Condition Name

Condition Name for LIPOFEN
Intervention Trials
Alcoholism 1
Cervical Intraepithelial Neoplasia 1
Diabetes Complications 1
Invasive Cervical Cancer 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for LIPOFEN
Intervention Trials
Alcoholism 1
Heart Diseases 1
Diabetes Mellitus, Type 2 1
Diabetes Mellitus 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for LIPOFEN

Trials by Country

Trials by Country for LIPOFEN
Location Trials
United States 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for LIPOFEN
Location Trials
California 1
Missouri 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for LIPOFEN

Clinical Trial Phase

Clinical Trial Phase for LIPOFEN
Clinical Trial Phase Trials
Phase 2 1
Phase 1 1
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for LIPOFEN
Clinical Trial Phase Trials
Completed 2
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for LIPOFEN

Sponsor Name

Sponsor Name for LIPOFEN
Sponsor Trials
Washington University School of Medicine 1
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 1
The Scripps Research Institute 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for LIPOFEN
Sponsor Trials
Other 4
NIH 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.